Table 2.
Relationship between clinical, pathological, and NLR in postoperative stage I NSCLC patients.
| Variables | N | Low NLR (%) | High NLR (%) | χ 2 | P value |
|---|---|---|---|---|---|
| Gender | 9.979 | 0.002 | |||
| Male | 97 | 70 (72.2) | 27 (27.8) | ||
| Female | 92 | 83 (90.2) | 9 (9.8) | ||
|
| |||||
| Age at diagnosis (years) | 0.625 | 0.429 | |||
| ≥65 | 68 | 53 (77.9) | 15 (22.1) | ||
| <65 | 121 | 100 (82.6) | 21 (17.4) | ||
|
| |||||
| Smoking history | 3.105 | 0.078 | |||
| Smoker | 70 | 52 (74.3) | 18 (13.4) | ||
| Nonsmoker | 118 | 100 (84.7) | 18 (15.3) | ||
|
| |||||
| Histologic type | 7.064 | 0.029 | |||
| Squamous | 26 | 17 (65.4) | 9 (34.6) | ||
| Adenocarcinoma | 145 | 123 (84.8) | 22 (15.2) | ||
| Others | 12 | 8 (66.7) | 4 (33.3) | ||
|
| |||||
| Stage | 4.288 | 0.232 | |||
| IA1 | 15 | 13 (86.7) | 2 (13.3) | ||
| IA2 | 79 | 68 (86.1) | 11 (13.9) | ||
| IA3 | 45 | 36 (80.0) | 9 (20.0) | ||
| IB | 50 | 36 (72.0) | 14 (28.0) | ||
|
| |||||
| Differentiation | 2.350 | 0.309 | |||
| Poor | 51 | 38 (74.5) | 13 (25.5) | ||
| Moderate | 38 | 33 (86.8) | 5 (13.2) | ||
| Well | 96 | 79 (82.3) | 17 (17.7) | ||
|
| |||||
| Chemotherapy | 0.082 | 0.775 | |||
| Yes | 109 | 89 (81.7) | 20 (18.3) | ||
| No | 80 | 64 (80.0) | 16 (20.0) | ||
|
| |||||
| Visceral pleural invasion | 0.001 | 0.980 | |||
| Absent | 163 | 132 (81.0) | 31 (19.0) | ||
| Present | 26 | 21 (80.0) | 5 (19.2) | ||
|
| |||||
| Lymphovascular invasion | 1.236 | 0.266 | |||
| Absent | 150 | 119 (79.3) | 31 (20.7) | ||
| Present | 39 | 34 (87.2) | 5 (12.8) | ||
|
| |||||
| Recurrence | 2.693 | 0.101 | |||
| Yes | 67 | 50 (74.6) | 17 (25.4) | ||
| No | 122 | 103 (84.4) | 19 (15.6) | ||
|
| |||||
| Survival | 15.990 | 0.001 | |||
| Yes | 153 | 130 (85.0) | 23 (15.0) | ||
| No | 24 | 12 (50.0) | 12 (50.0) | ||